Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03563651 · ClinicalTrials.gov registry record

Collection of Blood, Urine, and Stool to Monitor MetastaticColorectal Cancers

A clinical trial, sponsored by University of Southern California.

Completed
Registry status
29
Enrollment target

NCT03563651 is a clinical trial that has completed, run by University of Southern California. The registered enrollment target is 29 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03563651 has completed, sponsored by University of Southern California.

COMPLETED
Registry status
29 participants
Enrollment target

Study Summary

This trial studies the monitoring of therapy and progression by collecting blood, urine, and stool from participants with colorectal cancer that has spread to other places in the body or cannot be removed by surgery. Studying samples of blood, urine, and stool from participants with colorectal cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer.

Interventions

  • PROCEDURE Biospecimen Collection
  • PROCEDURE Biopsy
  • OTHER Laboratory Biomarker Analysis
  • OTHER Questionnaire Administration

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2014-02-06
Est. Completion 2020-05-28

Sponsor

University of Southern California

617 total trials

What the Registry Record Tells You About NCT03563651

The ClinicalTrials.gov registry entry for NCT03563651 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Biospecimen Collection is the first listed.

NCT03563651 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03563651 about?

NCT03563651 is a clinical study titled "Collection of Blood, Urine, and Stool to Monitor MetastaticColorectal Cancers". This trial studies the monitoring of therapy and progression by collecting blood, urine, and stool from participants with colorectal cancer that has spread to other places in the body or cannot be removed by surgery. Studying samples of blood, urine, and stool from participants with colorectal cance...

What is the current status of trial NCT03563651?

This trial is currently completed. The enrollment target is 29 participants. The study started on 2014-02-06. Estimated completion is 2020-05-28.

What interventions are being tested in trial NCT03563651?

The interventions under investigation include: Biospecimen Collection (PROCEDURE), Biopsy (PROCEDURE), Laboratory Biomarker Analysis (OTHER), Questionnaire Administration (OTHER).

Who is sponsoring clinical trial NCT03563651?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.